Forecast of Global ELISpot and FluoroSpot Assay 麻豆原创 Growth (Status and Outlook) 2019-2024

Publication ID:

PB24190053

Publication Date:

March 28, 2019

Pages:

117

Publisher:

MRRPB2

Countries:

Global [1]

USD 3,660.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Global ELISpot and FluoroSpot Assay market will register a 13.6% CAGR in terms of revenue, the global market size will reach USD 320 million by 2024, from USD 170 million in 2019.

The enzyme-linked immune absorbent spot (ELISpot) is a type of assay that focuses on quantitatively measuring the frequency of cytokine secretion for a single cell. The ELISpot Assay is also a form of immunostaining since it is classified as a technique that uses antibodies to detect a protein analyte, with the word analyte referring to any biological or chemical substance being identified or measured.
The classification of ELISpot and FluoroSpot Assay includes Assay Kit, Analyzer and Other related product. The proportion of Assay Kit in 2018 is about 62.38%, and the proportion is in increasing trend from 2013 to 2018.
North America is the largest consumption place, with a consumption market share nearly 32.3% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 24.7%
麻豆原创 competition is intense. Oxford Immunotec and Cellular Technology Limited, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

According to this study, over the next five years the ELISpot and FluoroSpot Assay market will register a 13.6% CAGR in terms of revenue, the global market size will reach US$ 320 million by 2024, from US$ 170 million in 2019. In particular, this report presents the global revenue market share of key companies in ELISpot and FluoroSpot Assay business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of ELISpot and FluoroSpot Assay market by product type, application, key companies and key regions.

This study considers the ELISpot and FluoroSpot Assay value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Assay Kit
Analyzer
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Diagnostic
Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Oxford Immunotec
Cellular Technology Limited
BD
AID GmbH
Mabtech
Bio-Techne
Lophius Biosciences
Abcam
Biotech Investissement Group
U-CyTech biosciences.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global ELISpot and FluoroSpot Assay market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of ELISpot and FluoroSpot Assay market by identifying its various subsegments.
Focuses on the key global ELISpot and FluoroSpot Assay players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the ELISpot and FluoroSpot Assay with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of ELISpot and FluoroSpot Assay submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.

Table Of Contents:

Table of Contents

2019-2024 Global ELISpot and FluoroSpot Assay 麻豆原创 Report (Status and Outlook)

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global ELISpot and FluoroSpot Assay 麻豆原创 Size 2014-2024
2.1.2 ELISpot and FluoroSpot Assay 麻豆原创 Size CAGR by Region
2.2 ELISpot and FluoroSpot Assay Segment by Type
2.2.1 Assay Kit
2.2.2 Analyzer
2.3 ELISpot and FluoroSpot Assay 麻豆原创 Size by Type
2.3.1 Global ELISpot and FluoroSpot Assay 麻豆原创 Size 麻豆原创 Share by Type (2014-2019)
2.3.2 Global ELISpot and FluoroSpot Assay 麻豆原创 Size Growth Rate by Type (2014-2019)
2.4 ELISpot and FluoroSpot Assay Segment by Application
2.4.1 Diagnostic
2.4.2 Research
2.5 ELISpot and FluoroSpot Assay 麻豆原创 Size by Application
2.5.1 Global ELISpot and FluoroSpot Assay 麻豆原创 Size 麻豆原创 Share by Application (2014-2019)
2.5.2 Global ELISpot and FluoroSpot Assay 麻豆原创 Size Growth Rate by Application (2014-2019)

3 Global ELISpot and FluoroSpot Assay by Players
3.1 Global ELISpot and FluoroSpot Assay 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global ELISpot and FluoroSpot Assay 麻豆原创 Size by Players (2017-2019)
3.1.2 Global ELISpot and FluoroSpot Assay 麻豆原创 Size 麻豆原创 Share by Players (2017-2019)
3.2 Global ELISpot and FluoroSpot Assay Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ELISpot and FluoroSpot Assay by Regions
4.1 ELISpot and FluoroSpot Assay 麻豆原创 Size by Regions
4.2 Americas ELISpot and FluoroSpot Assay 麻豆原创 Size Growth
4.3 APAC ELISpot and FluoroSpot Assay 麻豆原创 Size Growth
4.4 Europe ELISpot and FluoroSpot Assay 麻豆原创 Size Growth
4.5 Middle East & Africa ELISpot and FluoroSpot Assay 麻豆原创 Size Growth

5 Americas
5.1 Americas ELISpot and FluoroSpot Assay 麻豆原创 Size by Countries
5.2 Americas ELISpot and FluoroSpot Assay 麻豆原创 Size by Type
5.3 Americas ELISpot and FluoroSpot Assay 麻豆原创 Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC ELISpot and FluoroSpot Assay 麻豆原创 Size by Countries
6.2 APAC ELISpot and FluoroSpot Assay 麻豆原创 Size by Type
6.3 APAC ELISpot and FluoroSpot Assay 麻豆原创 Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe ELISpot and FluoroSpot Assay by Countries
7.2 Europe ELISpot and FluoroSpot Assay 麻豆原创 Size by Type
7.3 Europe ELISpot and FluoroSpot Assay 麻豆原创 Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa ELISpot and FluoroSpot Assay by Countries
8.2 Middle East & Africa ELISpot and FluoroSpot Assay 麻豆原创 Size by Type
8.3 Middle East & Africa ELISpot and FluoroSpot Assay 麻豆原创 Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends

10 Global ELISpot and FluoroSpot Assay 麻豆原创 Forecast
10.1 Global ELISpot and FluoroSpot Assay 麻豆原创 Size Forecast (2019-2024)
10.2 Global ELISpot and FluoroSpot Assay Forecast by Regions
10.2.1 Global ELISpot and FluoroSpot Assay Forecast by Regions (2019-2024)
10.2.2 Americas 麻豆原创 Forecast
10.2.3 APAC 麻豆原创 Forecast
10.2.4 Europe 麻豆原创 Forecast
10.2.5 Middle East & Africa 麻豆原创 Forecast
10.3 Americas Forecast by Countries
10.3.1 United States 麻豆原创 Forecast
10.3.2 Canada 麻豆原创 Forecast
10.3.3 Mexico 麻豆原创 Forecast
10.3.4 Brazil 麻豆原创 Forecast
10.4 APAC Forecast by Countries
10.4.1 China 麻豆原创 Forecast
10.4.2 Japan 麻豆原创 Forecast
10.4.3 Korea 麻豆原创 Forecast
10.4.4 Southeast Asia 麻豆原创 Forecast
10.4.5 India 麻豆原创 Forecast
10.4.6 Australia 麻豆原创 Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany 麻豆原创 Forecast
10.5.2 France 麻豆原创 Forecast
10.5.3 UK 麻豆原创 Forecast
10.5.4 Italy 麻豆原创 Forecast
10.5.5 Russia 麻豆原创 Forecast
10.5.6 Spain 麻豆原创 Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt 麻豆原创 Forecast
10.6.2 South Africa 麻豆原创 Forecast
10.6.3 Israel 麻豆原创 Forecast
10.6.4 Turkey 麻豆原创 Forecast
10.6.5 GCC Countries 麻豆原创 Forecast
10.7 Global ELISpot and FluoroSpot Assay Forecast by Type
10.8 Global ELISpot and FluoroSpot Assay Forecast by Application

11 Key Players Analysis
11.1 Oxford Immunotec
11.1.1 Company Details
11.1.2 ELISpot and FluoroSpot Assay Product Offered
11.1.3 Oxford Immunotec ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Oxford Immunotec News
11.2 Cellular Technology Limited
11.2.1 Company Details
11.2.2 ELISpot and FluoroSpot Assay Product Offered
11.2.3 Cellular Technology Limited ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Cellular Technology Limited News
11.3 BD
11.3.1 Company Details
11.3.2 ELISpot and FluoroSpot Assay Product Offered
11.3.3 BD ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 BD News
11.4 AID GmbH
11.4.1 Company Details
11.4.2 ELISpot and FluoroSpot Assay Product Offered
11.4.3 AID GmbH ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 AID GmbH News
11.5 Mabtech
11.5.1 Company Details
11.5.2 ELISpot and FluoroSpot Assay Product Offered
11.5.3 Mabtech ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Mabtech News
11.6 Bio-Techne
11.6.1 Company Details
11.6.2 ELISpot and FluoroSpot Assay Product Offered
11.6.3 Bio-Techne ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Bio-Techne News
11.7 Lophius Biosciences
11.7.1 Company Details
11.7.2 ELISpot and FluoroSpot Assay Product Offered
11.7.3 Lophius Biosciences ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Lophius Biosciences News
11.8 Abcam
11.8.1 Company Details
11.8.2 ELISpot and FluoroSpot Assay Product Offered
11.8.3 Abcam ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Abcam News
11.9 Biotech Investissement Group
11.9.1 Company Details
11.9.2 ELISpot and FluoroSpot Assay Product Offered
11.9.3 Biotech Investissement Group ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Biotech Investissement Group News
11.10 U-CyTech biosciences.
11.10.1 Company Details
11.10.2 ELISpot and FluoroSpot Assay Product Offered
11.10.3 U-CyTech biosciences. ELISpot and FluoroSpot Assay Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 U-CyTech biosciences. News

12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.